{"categories":["\u7c73\u56fd\u682a"],"type":"rich","provider_name":"Hatena Blog","author_url":"https://blog.hatena.ne.jp/koto-x/","height":"190","image_url":"https://cdn-ak.f.st-hatena.com/images/fotolife/k/koto-x/20180111/20180111022203.jpg","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Finvestor-2017.hatenablog.com%2Fentry%2F2020%2F02%2F10%2F070000\" title=\"\u7c73\u56fd\u682a Accenture (NYSE: ACN)\u306b\u6295\u8cc7\u5b9f\u884c (1) - \u30a2\u30a4\u30c7\u30a2\u6295\u8cc7\u5bb6\u3000\u8cc7\u7523\u904b\u7528\u3068\u751f\u6d3b\u4e00\u5de5\u592b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","blog_url":"https://investor-2017.hatenablog.com/","description":"\u7c73\u56fd\u682a\u3078\u306e\u6295\u8cc7\u5b9f\u884c\u306f\u3001\u524d\u56deNeurocrine Biosciences <NASDAQ: NBIX>\u3092\u7d39\u4ecb\u3057\u305f\u3002 \u4eca\u56de\u306f\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u3001\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30a2\u30a6\u30c8\u30bd\u30fc\u30b7\u30f3\u30b0\u3092120\u304b\u56fd\u3067\u63d0\u4f9b\u3059\u308bAccenture <NYSE: ACN>\u3078\u306e\u6295\u8cc7\u306b\u81f3\u3063\u305f\u6295\u8cc7\u30b5\u30fc\u30d3\u30b9Motley\u306e\u63a8\u5968\u7406\u7531\u3092\u8907\u6570\u56de\u306b\u5206\u3051\u3066\u7d39\u4ecb\u3059\u308b\u3002 \u30fbAccenture \u6295\u8cc7\u5bb6\u5411\u3051\u30da\u30fc\u30b8 investor.accenture.com \u30fbAccenture\u306e\u682a\u4fa1\u63a8\u79fb TradingView\u63d0\u4f9b\u306b\u3088\u308bAccenture\u30c1\u30e3\u30fc\u30c8 \u305d\u308c\u3067\u306f\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u3084\u30a2\u30a6\u30c8\u30bd\u30fc\u30b7\u30f3\u30b0\u3092\u884c\u3046Accenture\u3092\u7d39\u4ecb\u3059\u308b\u3002 \u30fb\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u4f01\u696d\u3092\u3001\u4f01\u696d\u5411\u2026","url":"https://investor-2017.hatenablog.com/entry/2020/02/10/070000","published":"2020-02-10 07:00:00","provider_url":"https://hatena.blog","title":"\u7c73\u56fd\u682a Accenture (NYSE: ACN)\u306b\u6295\u8cc7\u5b9f\u884c (1)","width":"100%","version":"1.0","blog_title":"\u30a2\u30a4\u30c7\u30a2\u6295\u8cc7\u5bb6\u3000\u8cc7\u7523\u904b\u7528\u3068\u751f\u6d3b\u4e00\u5de5\u592b","author_name":"koto-x"}